News: A new role for aspirin/ibuprofen in breast Ca?

Article

Regular use of NSAIDs may reduce a woman's risk of breast Ca.

Regular use of nonsteroidal anti-inflammatory drugs (NSAIDs), including aspirin and ibuprofen, may reduce a woman's risk for breast cancer, according to the results of a recent meta-analysis.

Researchers included a total of 38 studies (16 case–control, 18 cohort, three case–control nested in well-defined cohorts, and one clinical trial) performed in five countries, involving both COX-2–selective and –nonselective inhibitors.

Use of any NSAID was associated with about a 12% reduction in breast cancer risk (random effects pooled RR=0.88; 95% CI, 0.84–0.93). Aspirin or ibuprofen was associated with similar risk reductions (RR=0.87; 95% CI, 0.82–0.92; and RR=0.79; 95% CI, 0.64–0.97, respectively). In general, associations were stronger in case–control than in cohort studies, but the researchers noted that this may be due to recall bias.

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Recent Videos
Thomas McElrath, MD, PhD, highlights limitations of current preeclampsia guidelines | Image Credit: physiciandirectory.brighamandwomens.org.
Jane Varney, MD, discusses how a low FODMAP diet mediates gut symptoms caused by endometriosis | Image Credit: lens.monash.edu.
Ousseny Zerbo, PhD, highlights benefits of influenza vaccination during pregnancy | Image Credit: divisionofresearch.kaiserpermanente.org.
Michael Ussher, PhD, highlights the benefits of vaping over smoking in pregnancy | Image Credit: sgul.ac.uk.
Neal Barnard, MD, FACC, highlights AMA's new breast cancer prevention guidelines | Image Credit: pcrm.org.
Related Content
© 2025 MJH Life Sciences

All rights reserved.